Form 4 Tracker
STANDARD BIOTOOLS INC.
LAB

9 insider filings · Latest: Mar 20, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 23, 2025May 23 8:19 PMMackay Sean
Proposed Sale
13,217$0.9413$12.4K

View →

May 23, 2025May 23 8:18 PMKim Hanjoon Alex
Proposed Sale
1,428$0.9413$1.3K

View →

May 23, 2025May 23 8:09 PMEgholm Michael
Proposed Sale
5,473$0.9413$5.2K

View →

May 22, 2025May 22 8:20 PMEgholm Michael
Proposed Sale
5,116$1.00$5.1K

View →

May 22, 2025May 22 8:13 PMMackay Sean
Proposed Sale
12,536$1.00$12.6K

View →

May 22, 2025May 22 8:07 PMKim Hanjoon Alex
Proposed Sale
1,355$1.00$1.4K

View →

May 21, 2025May 21 8:22 PMKim Hanjoon Alex
Proposed Sale
1,407$1.03$1.5K

View →

May 21, 2025May 21 8:16 PMMackay Sean
Proposed Sale
12,838$1.03$13.2K

View →

May 21, 2025May 21 8:13 PMEgholm Michael
Proposed Sale
4,719$1.03$4.9K

View →

Nov 12, 2024Nov 12 9:13 PMBlack Jeffrey G.
Proposed Sale
57,971$2.12$123.1K

View →

Sep 9, 2024Sep 9 7:19 PMTaich Adam
Proposed Sale
45,851$2.00$91.7K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Apr 6, 2026Apr 9 1:55 AMMichael EgholmDirector, President & CEO
Option Exercise
196,5130(D)

View →

Mar 20, 2026Apr 9 1:55 AMMichael EgholmDirector, President & CEO
Grant/Award
2,345,340$0.98462,345,340(D)

View →

Mar 20, 2026Apr 9 1:55 AMSean MackaySVP & Chief Business Officer
Grant/Award
612,240$0.9846612,240(D)

View →

Apr 6, 2026Apr 9 1:55 AMHanjoon Alex KimChief Financial Officer
Option Exercise
70,1830(D)

View →

Mar 20, 2026Apr 9 1:55 AMHanjoon Alex KimChief Financial Officer
Grant/Award
727,140$0.9846727,140(D)

View →